Rapid determination of omeprazole in human plasma by protein precipitation and liquid chromatography-tandem mass spectrometry
Language English Country Netherlands Media print-electronic
Document type Journal Article, Validation Study
PubMed
17293174
DOI
10.1016/j.jchromb.2007.01.026
PII: S1570-0232(07)00070-0
Knihovny.cz E-resources
- MeSH
- Chemical Precipitation MeSH
- Mass Spectrometry methods MeSH
- Enzyme Inhibitors blood pharmacokinetics MeSH
- Blood Proteins metabolism MeSH
- Humans MeSH
- Omeprazole blood pharmacokinetics MeSH
- Anti-Ulcer Agents blood pharmacokinetics MeSH
- Reference Standards MeSH
- Reproducibility of Results MeSH
- Sensitivity and Specificity MeSH
- Chromatography, High Pressure Liquid methods MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Validation Study MeSH
- Names of Substances
- Enzyme Inhibitors MeSH
- Blood Proteins MeSH
- Omeprazole MeSH
- Anti-Ulcer Agents MeSH
A rapid, sensitive and reliable method was developed to quantitate omeprazole in human plasma using liquid chromatography-tandem mass spectrometry. The assay is based on protein precipitation with acetonitrile and reversed-phase liquid chromatography performed on an octadecylsilica column (55 mm x 2mm, 3 microm particles), the mobile phase consisted of methanol-10 mM ammonium acetate (60:40, v/v). Omeprazole and flunitrazepam, the internal standard, elute at 0.80+/-0.10 min with a total run time 1.35 min. Quantification was through positive ion mode and selected reaction monitoring mode at m/z 346.1-->197.9 for omeprazole and m/z 314.0-->268.0 for flunitrazepam, respectively. The lower limit of quantitation was 1.2 ng/ml using 0.25 ml of plasma and linearity was observed from 1.2 to 1200 ng/ml. Within-day and between-day precision expressed by relative standard deviation was less than 5% and inaccuracy did not exceed 12%. The assay was applied to the analysis of samples from a pharmacokinetic study.
References provided by Crossref.org